Tamaskovics, BF; Hecht, M; Schubert, P; Kallies, A; Illmer, T; Radke, J; Koelbl, O; Steger, F; Brunner, TB; Rödel, C; Fleischmann, M; Reinacher-Schick, A; Wingender, LF; Melchior, P; Klautke, G; Hintzen, U; Gaipl, US; Haussmann, J; Budach, W; Fietkau, R.
Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial
ANN ONCOL. 2023; 34: S593-S593.
Doi: 10.1016/j.annonc.2023.09.2088
[Poster]
Web of Science
FullText
FullText_MUG